Calidi Biotherapeutics Inc (CLDI)
0.23
-0.01
(-3.64%)
USD |
NYAM |
May 24, 15:42
Calidi Biotherapeutics Cash and Short Term Investments (Quarterly): 1.143M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.143M |
December 31, 2023 | 1.949M |
September 30, 2023 | 10.15M |
June 30, 2023 | 1.918M |
Date | Value |
---|---|
December 31, 2022 | 0.372M |
September 30, 2022 | 0.20M |
December 31, 2021 | 2.137M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.20M
Minimum
Sep 2022
10.15M
Maximum
Sep 2023
2.552M
Average
1.918M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
Minerva Neurosciences Inc | 34.82M |
Viking Therapeutics Inc | 962.98M |
CytomX Therapeutics Inc | 150.28M |
Genprex Inc | 8.217M |
Janux Therapeutics Inc | 651.76M |